1. Home
  2. MATH vs MIST Comparison

MATH vs MIST Comparison

Compare MATH & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metalpha Technology Holding Limited

MATH

Metalpha Technology Holding Limited

N/A

Current Price

$1.00

Market Cap

49.9M

Sector

Finance

ML Signal

N/A

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

N/A

Current Price

$0.68

Market Cap

95.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MATH
MIST
Founded
2015
2003
Country
Hong Kong
Canada
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.9M
95.3M
IPO Year
2016
2019

Fundamental Metrics

Financial Performance
Metric
MATH
MIST
Price
$1.00
$0.68
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $5.57
AVG Volume (30 Days)
32.9K
★ 925.0K
Earning Date
08-06-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$125.44
Revenue Next Year
N/A
$462.63
P/E Ratio
$3.10
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.63
52 Week High
$3.19
$3.06

Technical Indicators

Market Signals
Indicator
MATH
MIST
Relative Strength Index (RSI) 48.20 41.44
Support Level $0.93 $0.63
Resistance Level $1.18 $0.84
Average True Range (ATR) 0.09 0.07
MACD -0.01 0.00
Stochastic Oscillator 41.68 18.87

Price Performance

Historical Comparison
MATH
MIST

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd mainly operates in the trading of proprietary digital assets and derivative contracts in Hong Kong. The Company's primary business operations center on digital asset services, offered through its subsidiaries. The Company generates income mainly from executing cryptocurrency-related transactions, including providing derivative solutions to over-the-counter (OTC) clients, issuing derivative products to OTC clients, and engaging in proprietary trading activities. The Company provides crypto derivative solutions and liquidity to its clients, facilitated through its principal trading activities, enabling seamless trading of crypto derivative solutions. The Company generates revenue from Hong Kong.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.

Share on Social Networks: